Skip to content

Protective Effect of Beraprost Sodium Tablets on Reperfusion Therapy for Acute STEMI

Protective Effect of Beraprost Sodium Tablets on Coronary Microcirculation Function and Ventricular Remodeling After Reperfusion Therapy for Acute ST Segment Elevation Myocardial Infarction

Status
UNKNOWN
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05103813
Enrollment
100
Registered
2021-11-02
Start date
2022-05-01
Completion date
2023-06-30
Last updated
2022-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Essential Hypertension

Brief summary

Protective effect of Beraprost Sodium Tablets on coronary microcirculation function and ventricular remodeling after reperfusion therapy for acute ST segment elevation myocardial infarction

Interventions

Protective effect of Beraprost Sodium Tablets on coronary microcirculation function and ventricular remodeling after reperfusion therapy for acute ST segment elevation myocardial infarction

Sponsors

Shenzhen People's Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* It meets the diagnostic criteria of acute ST segment elevation myocardial infarction: ischemic chest pain lasts for more than 30 minutes and can not be relieved by taking nitroglycerin; ST segment elevation of ECG with two or more adjacent leads, limb lead ≥ 1mm, chest lead ≥ 2mm; Or new left bundle branch block; The serum markers of myocardial necrosis increased at least twice the normal value * Acute myocardial infarction was confirmed by coronary angiography * The clinical and angiographic data were complete * Direct PCI was performed within 12 hours after onset

Exclusion criteria

* Those who do not cooperate in the inspection, have poor compliance and cannot guarantee the completion of the test * Conscious disorder, obvious intellectual disorder and mental disorder * With metal foreign bodies, such as metal prosthesis, intraocular metal foreign bodies, intracranial aneurysm clamp, etc * People with claustrophobia * Had a history of myocardial infarction, PCI and coronary artery bypass grafting * Factors affecting ST segment changes of ECG: complete left bundle branch block, preexcitation syndrome, pacemaker ECG, etc

Design outcomes

Primary

MeasureTime frameDescription
Major Adverse Cardiovascular Events1 weeks after baselineThe incidence of mace after 1 week of treatment

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026